Table 2.
Indications and contraindications for IABP and Impella devices
| Considerations | IABP | Impella |
|---|---|---|
| Duration | Days | 4-6 d |
| Indications | ||
| LV failure | LV failure within 2 d of MI or heart surgery | |
| Prophylactic support for high-risk PCI | Acute LV failure from cardiomyopathy | |
| Prophylactic support for severe mitral regurgitation or preoperative low cardiac output state | ||
| Postoperative uncontrolled myocardial ischemia | ||
| Contraindications | ||
| Significant aortic valve regurgitation | Significant aortic valve regurgitation | |
| Aortic aneurysm or dissection | Mechanical aortic valve prosthesis | |
| Significant peripheral vascular disease | Significant peripheral vascular disease | |
| Uncontrolled sepsis | Mural thrombus in left ventricle | |
| Uncontrolled bleeding | Ventricular septal defect | |
| LV myocardial rupture | ||
| Refractory respiratory failure requiring oxygenator | ||
| Cardiac tamponade |
IABP, Intra-aortic balloon pump; LV, left ventricle; MI, myocardial infarction; PCI, percutaneous coronary intervention.